Edition:
United States

Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

32.14USD
4:00pm EDT
Change (% chg)

$0.02 (+0.06%)
Prev Close
$32.12
Open
$32.13
Day's High
$32.28
Day's Low
$32.08
Volume
4,710,141
Avg. Vol
6,617,399
52-wk High
$37.39
52-wk Low
$29.83

PFE.N

Chart for PFE.N

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $201,581.00
Shares Outstanding(Mil.): 5,955.13
Dividend: 0.32
Yield (%): 3.78

Financials

  PFE.N Industry Sector
P/E (TTM): 29.03 29.41 30.38
EPS (TTM): 1.17 -- --
ROI: 5.20 13.85 13.36
ROE: 11.58 14.79 14.50

AstraZeneca asthma shot hits goal but diabetes drug lags rival

LONDON AstraZeneca's experimental injection for severe asthma cut substantially the need for patients to take problematic oral steroid drugs in a late-stage study, boosting hopes for a medicine that is expected to reach the market later this year.

4:29am EDT

Severe asthma drug shows AstraZeneca promise beyond cancer

LONDON, May 22 AstraZeneca's experimental injection for severe asthma cut substantially the need for patients to take problematic oral steroids drugs in a late-stage study, boosting hopes for a medicine that is expected to reach the market later this year.

May 22 2017

CHMP backs Novartis's Zykadia for first-line use in lung cancer

ZURICH Novartis's push to win approval for Zykadia as an initial treatment for a type of lung cancer got a lift on Friday with a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

May 19 2017

CHMP backs Novartis's Zykadia for first-line use in lung cancer

ZURICH Novartis's push to win approval for Zykadia as an initial treatment for a type of lung cancer got a lift on Friday with a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

May 19 2017

CHMP backs Novartis's Zykadia for first-line use in lung cancer

ZURICH, May 19 Novartis's push to win approval for Zykadia as an initial treatment for a type of lung cancer got a lift on Friday with a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

May 19 2017

Merck KGaA TV crystals sales decline raises stakes for cancer drug

FRANKFURT Merck KGaA's sales of liquid crystals used in flat-screen TVs are now expected to decline this year, making the German company more reliant on its new cancer immunotherapy drug to fuel growth.

May 18 2017

UPDATE 1-Merck KGaA TV crystals sales decline raises stakes for cancer drug

* Sees 2017 adjusted earnings of 4.4 bln-4.6 bln euros (Adds analyst, CFO quotes, details on crystals, cancer drug)

May 18 2017

Pfizer drug from Medivation deal shows promise in breast cancer: study

A breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior treatments and a modest ability to hold the disease in check, according to data from a mid-stage study released on Wednesday.

May 17 2017

Pfizer drug from Medivation deal shows promise in breast cancer -study

May 17 A breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior treatments and a modest ability to hold the disease in check, according to data from a mid-stage study released on Wednesday.

May 17 2017

US STOCKS-S&P 500, Dow end session flat, tech boosts Nasdaq

* Dow down 0.01 pct, S&P down 0.07 pct, Nasdaq up 0.3 pct (Updates to close, adds commentary)

May 16 2017

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $127.52 +0.26
Novartis AG (NOVN.S) CHF79.05 -0.35
Merck & Co., Inc. (MRK.N) $64.55 +0.51
Roche Holding Ltd. (ROG.S) CHF267.90 0.00
Roche Holding Ltd. (RO.S) CHF267.25 -0.50
Abbott Laboratories (ABT.N) $43.68 -0.05
Bayer AG (BAYGn.DE) €118.05 +1.45
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €87.82 +0.07
AstraZeneca plc (AZN.L) 5,141.00 +11.00

Earnings vs. Estimates